The editorial was published in the Eli Lillys retatrutide, a triple hormone receptor agonist, has demonstrated an average weight loss of 28.3% over 80 weeks on the highest dose in Phase 3 trials
Ozempic is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that slows down stomach emptying
These are rare at the doses used in supervised clinical care and when they occur, they're typically mild and transient
Goldwaser: A lot of athletes of all calibers, ages and types are asking me about how peptides are going to enhance performance
Journal of the American Academy of Dermatology, Volume 91, Issue 1, 166 168
First, muscle loss lowers your resting metabolic rate, which means you burn fewer calories at rest making weight regain more likely if you ever stop the medication